Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)

NCT01485614 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus
Type 2 Diabetes

Interventions

DRUG: Sitagliptin
DRUG: Metformin
DRUG: Placebo to sitagliptin
DRUG: Placebo to metformin
DRUG: Glycemic Rescue 1
BIOLOGICAL: Glycemic Rescue 2

Sponsor

Merck Sharp & Dohme LLC